A RANDOMIZED PHASE II STUDY OF TWO DOSES OF INTERFERON ALFA-2A (IFN ALFA-2A) IN COMBINATION WITH ZIDOVUDINE (AZT) AND DIDEOXYCYTIDINE (DDC) VERSUS AZT AND DDC ONLY IN PATIENTS WITH HIV INFECTION AND LESS THAN 400 CD4 CELLS/MM3: